In today’s poultry industry, producers face a dual challenge – maintaining optimal gut function to drive production performance and welfare, while also meeting growing environmental requirements like carbon footprint reduction. Gut imbalances and pathogen pressures can negatively impact feed efficiency, constrain growth, and increase disease risks. And with the average chicken’s gut transit time just 4-6 hours, conventional probiotics often struggle to deliver their full benefits.
Innovative solutions are needed to deliver the full probiotic benefits within this very short transition time, while also enhancing productivity and contributing to sustainability goals.
Developed by Phileo, Microsaf® is a unique multi-species probiotic powered by exclusive GO Technology®. This carefully formulated blend of three proprietary Bacillus strains, Bacillus amyloliquefaciens, Bacillus licheniformis, Bacillus pumilus, is designed to promote optimal gut function, enhance performance metrics, and drive environmental sustainability – all while overcoming the industry’s toughest challenges.
Microsaf® has shown high capacity lactic acid production and consistent effects in the inhibition of major poultry pathogens such as Clostridium perfringens. In addition, GO Technology® allows Microsaf® to germinate under challenging conditions due to the short transit time in chickens, mitigating the negative impacts of acidic pH and bile salts.
In a trial conducted in the US, broilers supplemented with Microsaf® exhibited significantly better final body weight and FCR compared to the control group, under mild dysbiosis stress. By supporting optimal digestive function, Microsaf® empowers poultry producers to overcome dysbiosis challenges and unlock the full growth potential of their flocks.
Opportunistic pathogens like Enterococcus cecorum pose a significant threat to poultry producers, causing costly lameness issues that impact bird welfare and productivity. Microsaf®‘s unique blend of Bacillus strains has demonstrated the ability to significantly inhibit the growth of Enterococcus cecorum.
In a trial conducted in the US, the Microsaf®-supplemented group showed over a two-fold decrease in Enterococcus cecorum levels compared to the birds in the control group. A significant improvement of FCR has been observed in the same study. By controlling the prevalence of this opportunistic pathogen, Microsaf® helps mitigate lameness risks and support overall bird welfare and productivity.
To meet evolving consumer demands, poultry producers need to optimize feed efficiency, productivity, and reduce environmental impact. Microsaf® has proven its ability to boost key performance metrics, with trials showing improvements of up to 4-5 points in FCR and over 100g increases in body weight gain compared to control groups.
Additionally, Life Cycle Assessments* reveal Microsaf® can reduce the carbon footprint of broiler production by 5.4% – empowering producers to optimize profitability while also meeting growing sustainability requirements.
Microsaf® is the association of 3 Bacillus species selected through a battery of screening tests from a library of proprietary strains.
Microsaf® is a spore-forming bacteria probiotic with a high resistance to feed processes, such as high temperatures during pelleting or the heat treatment of mash feed.
Microsaf® is available in three different concentrations:
Microsaf® GT 3B-2 and Microsaf® GT 3B-8, suitable for directly supplementing complete feeds
Microsaf® GT 3B-50, suitable for incorporation into a premix
By priming the germination process with combined germinant factors for faster activation, GO Technology® can accelerate and synchronise Bacillus spore germination, mitigating the impact of challenging conditions such as acidic pH and the presence of bile salts.
Bacillus spores has shown that GO Technology® innovation successfully accelerated and synchronised the germination of the 3 Microsaf® strains. This enabled primed Bacillus licheniformis spores to reach 90% germination in just 45 minutes, a level reached by only 10% of the spores in the control group.
The 3 Bacillus strains are chosen for their complementary mode of action. Microsaf® combines Bacillus amyloliquefaciens, which is the best performing strain for producing enzymes; Bacillus licheniformis, which is the best performing strain for producing lactic acid, and Bacillus pumilus, which is the best performing strain for phagocytosis activation. All 3 strains have a strong ability to inhibit major poultry pathogens, such as Clostridium perfringens, Escherichia coli (E. coli), Salmonella, Campylobacter jejuni and Staphylococcus aureus.
The information provided in this document is to the best of our knowledge, true and accurate. Not all products are available in all regions nor are the associated intended uses and/or claims the same in all regions. Products must only be used in compliance with local laws and regulations and we cannot guarantee freedom for every intended use or country.
Packaging
Shelflife
Dosage